印度止咳糖漿逾20童服用後死亡,有毒「二甘醇」超標近500倍,WHO警告停用3款藥

julia 2025-10-15 11:37:00 CST印度三款止咳糖漿含超標有毒物二甘醇 (DEG),已致逾20名兒童死亡。印度當局已勒令相關藥廠停產並逮捕涉案人。世界衛生組織 (WHO)昨日發布健康諮詢警告,呼籲民眾不要使用和分發三款止咳糖漿。
https://www.thenewslens.com/article/259841
#世界衛生組織 #Coldrif #止咳糖漿 #DEG #印度 #Respifresh TR #WHO #印太 #二甘醇 #兒童死亡 #ReLife

印度止咳糖漿逾20童服用後死亡,有毒「二甘醇」超標近500倍,WHO警告停用3款藥 - TNL The News Lens 關鍵評論網

印度三款止咳糖漿含超標有毒物二甘醇 (DEG),已致逾20名兒童死亡。印度當局已勒令相關藥廠停產並逮捕涉案人。世界衛生組織 (WHO)昨日發布健康諮詢警告,呼籲民眾不要使用和分發三款止咳糖漿。

TNL The News Lens 關鍵評論網

CDSCO Writes To Tamil Nadu FDA, Seeks Strictest Action on ‘Coldrif’ Manufacturer

CDSCO Writes To Tamil Nadu FDA, Seeks Strictest Action on ‘Coldrif’ Manufacturer #cdsco #tamilnadu #fda #coldrif #otvnewsenglish #otvnews --------------------------------------------------------------------------------------------------------- OdishaTV is Odisha's no 1 News Channel. OTV being the first private satellite TV channel in Odisha carries the onus of charting a course that…

https://www.odnews.in/cdsco-writes-to-tamil-nadu-fda-seeks-strictest-action-on-coldrif-manufacturer/

The Central Drugs Standard Control Organisation (CDSCO) is set to take stringent action against Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup, following reports of several child fatalities linked to the product, ANI reported, citing sources. https://english.mathrubhumi.com/news/india/cdsco-to-urge-tn-fda-to-take-strict-action-against-coldrif-syrup-manufacturer-sources-kbkaerjk?utm_source=dlvr.it&utm_medium=mastodon #CDSCO #CoughSyrup #LatestNews #Coldrif #LatestNews
Kerala suspends Coldrif cough syrup sales and distribution statewide as a precautionary measure due to safety concerns https://english.mathrubhumi.com/news/kerala/kerala-coldrif-syrup-suspension-safety-srkypyku?utm_source=dlvr.it&utm_medium=mastodon #coldrif #coughsyrup #sale #kerala #minister